"","ID","logFC","logCPM","F","PValue","From","Entry","Reviewed","Entry.Name","Protein.names","Gene.Names","Function..CC.","Gene.Names..primary.","Gene.Ontology..GO.","Interacts.with","Subcellular.location..CC.","Ensembl","FDR"
"440","AMIGO2",0.552220192210299,8.92071170656727,36.712965879704,1.91246095570375e-08,"Q86SJ2","Q86SJ2","reviewed","AMGO2_HUMAN","Amphoterin-induced protein 2 (AMIGO-2) (Alivin-1) (Differentially expressed in gastric adenocarcinomas) (DEGA)","AMIGO2 ALI1","FUNCTION: Required for depolarization-dependent survival of cultured cerebellar granule neurons. May mediate homophilic as well as heterophilic cell-cell interaction with AMIGO1 or AMIGO3. May contribute to signal transduction through its intracellular domain. May be required for tumorigenesis of a subset of gastric adenocarcinomas.","AMIGO2","integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; brain development [GO:0007420]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of apoptotic process [GO:0043066]; negative regulation of programmed cell death [GO:0043069]; positive regulation of synapse assembly [GO:0051965]","O00555; Q6PL24","SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Single-pass type I membrane protein {ECO:0000250}. Nucleus {ECO:0000250}. Note=Associated with nucleus as well as plasma membrane. Restricted to somata of cerebellar as well as hippocampal neurons (By similarity). {ECO:0000250}.","ENST00000266581.4;ENST00000429635.1;ENST00000550413.2;",1.87000432248713e-05
"835","ASNS",0.914808537644021,7.10443843434948,43.4288074698126,2.64871695173159e-09,"P08243","P08243","reviewed","ASNS_HUMAN","Asparagine synthetase [glutamine-hydrolyzing] (EC 6.3.5.4) (Cell cycle control protein TS11) (Glutamine-dependent asparagine synthetase)","ASNS TS11","","ASNS","cytosol [GO:0005829]; asparagine synthase (glutamine-hydrolyzing) activity [GO:0004066]; ATP binding [GO:0005524]; asparagine biosynthetic process [GO:0006529]; cellular response to glucose starvation [GO:0042149]; glutamine metabolic process [GO:0006541]; L-asparagine biosynthetic process [GO:0070981]; negative regulation of apoptotic process [GO:0043066]; positive regulation of mitotic cell cycle [GO:0045931]","Q86WT6; Q86WT6-2; A2RRH5","","ENST00000175506.8 [P08243-1];ENST00000394308.8 [P08243-1];ENST00000394309.7 [P08243-1];ENST00000422745.5 [P08243-2];ENST00000437628.5 [P08243-3];ENST00000444334.5 [P08243-2];ENST00000455086.5 [P08243-3];",3.04695933576841e-06
"2620","CSTA",1.78139737510288,3.04926750591175,27.2875046536065,8.27501402450654e-07,"P01040","P01040","reviewed","CYTA_HUMAN","Cystatin-A (Cystatin-AS) (Stefin-A) [Cleaved into: Cystatin-A, N-terminally processed]","CSTA STF1 STFA","FUNCTION: This is an intracellular thiol proteinase inhibitor. Has an important role in desmosome-mediated cell-cell adhesion in the lower levels of the epidermis. {ECO:0000269|PubMed:21944047}.","CSTA","cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; peptidase inhibitor complex [GO:1904090]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; protease binding [GO:0002020]; cell-cell adhesion [GO:0098609]; keratinocyte differentiation [GO:0030216]; negative regulation of peptidase activity [GO:0010466]; negative regulation of proteolysis [GO:0045861]; peptide cross-linking [GO:0018149]","G5E9A7; P28799; P04792; Q9Y3C5; Q7Z699; O76024; P00784","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:21944047}.","ENST00000264474.4;",0.00057795062236875
"3442","EIF4A2",0.511541175686412,8.0910279161715,26.9210267912835,9.63646940512135e-07,"Q14240","Q14240","reviewed","IF4A2_HUMAN","Eukaryotic initiation factor 4A-II (eIF-4A-II) (eIF4A-II) (EC 3.6.4.13) (ATP-dependent RNA helicase eIF4A-2)","EIF4A2 DDX2B EIF4F","FUNCTION: ATP-dependent RNA helicase which is a subunit of the eIF4F complex involved in cap recognition and is required for mRNA binding to ribosome. In the current model of translation initiation, eIF4A unwinds RNA secondary structures in the 5'-UTR of mRNAs which is necessary to allow efficient binding of the small ribosomal subunit, and subsequent scanning for the initiator codon.","EIF4A2","cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]; cellular response to leukemia inhibitory factor [GO:1990830]; cytoplasmic translational initiation [GO:0002183]; negative regulation of RNA-directed 5'-3' RNA polymerase activity [GO:1900260]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]","Q7L190; P04792; Q9UI26; Q53EL6; Q7RTY1; Q9Y2D8; Q9NQ86; Q9HCM9; PRO_0000037577 [P27958]; P54253; Q96D03; Q7L190; P42858; Q99750; Q53EL6; Q8WWB5; Q9Y2D8; Q9NQ86; Q9HCM9; Q6ZNG0","","ENST00000323963.10 [Q14240-1];ENST00000440191.6 [Q14240-2];",0.000649830329953631
"5258","ENSG00000236698",3.3268009413157,4.58921912816568,30.8772424367541,3.3773674789337e-07,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.000300217265536488
"5944","ENSG00000251562",0.835701755636762,11.9792808491584,36.3262173971536,3.58182484882483e-07,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.000304548551059211
"9424","ESF1",0.585028197306967,7.05956882479462,28.0494412503071,6.03788572694731e-07,"Q9H501","Q9H501","reviewed","ESF1_HUMAN","ESF1 homolog (ABT1-associated protein)","ESF1 ABTAP C20orf6 HDCMC28P","FUNCTION: May constitute a novel regulatory system for basal transcription. Negatively regulates ABT1 (By similarity). {ECO:0000250}.","ESF1","extracellular space [GO:0005615]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; rRNA processing [GO:0006364]","","SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}. Nucleus, nucleoplasm {ECO:0000250}.","ENST00000202816.5;ENST00000617257.2;",0.000454141897216083
"12632","MRPL32",0.791203848299265,5.63395463270974,21.0333301096523,1.19128124358145e-05,"Q9BYC8","Q9BYC8","reviewed","RM32_HUMAN","39S ribosomal protein L32, mitochondrial (L32mt) (MRP-L32) (Mitochondrial large ribosomal subunit protein bL32m)","MRPL32 HSPC283","","MRPL32","mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412]","Q9GZV8","SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:25278503, ECO:0000269|PubMed:25838379, ECO:0000269|PubMed:28892042}.","ENST00000223324.3;",0.00597351179473819
"12766","MTHFD2",0.55944587565868,8.95841283609643,26.2150025820733,1.91900780950396e-06,"A0A7I2V2G4","A0A7I2V2G4","unreviewed","A0A7I2V2G4_HUMAN","Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial","MTHFD2","","MTHFD2","","","","ENST00000677377.1;",0.00121058441040837
"12990","NBPF15",0.809325482652259,5.8815009840991,26.3995733314726,2.76280404993851e-06,"Q8N660","Q8N660","reviewed","NBPFF_HUMAN","Neuroblastoma breakpoint family member 15 (Neuroblastoma breakpoint family member 16)","NBPF15 NBPF16","","NBPF15","cytoplasm [GO:0005737]","","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}.","ENST00000488031.6;ENST00000577412.6;ENST00000581897.7;",0.00168841862501867
"14792","PSAT1",0.645487213321509,6.23292843913023,20.6749973858417,1.79649887880636e-05,"Q9Y617","Q9Y617","reviewed","SERC_HUMAN","Phosphoserine aminotransferase (EC 2.6.1.52) (Phosphohydroxythreonine aminotransferase) (PSAT)","PSAT1 PSA","FUNCTION: Catalyzes the reversible conversion of 3-phosphohydroxypyruvate to phosphoserine and of 3-hydroxy-2-oxo-4-phosphonooxybutanoate to phosphohydroxythreonine. {ECO:0000250|UniProtKB:P10658}.","PSAT1","cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; identical protein binding [GO:0042802]; O-phospho-L-serine:2-oxoglutarate aminotransferase activity [GO:0004648]; pyridoxal phosphate binding [GO:0030170]; L-serine biosynthetic process [GO:0006564]; pyridoxine biosynthetic process [GO:0008615]","P27797; P12830; P36957; Q8TDX7; Q9Y617","","ENST00000347159.6 [Q9Y617-2];ENST00000376588.4 [Q9Y617-1];",0.00856886148144809
"16479","SLC7A11",0.913578317255629,7.01635464108562,54.6572106042253,1.24209037471324e-10,"Q9UPY5","Q9UPY5","reviewed","XCT_HUMAN","Cystine/glutamate transporter (Amino acid transport system xc-) (Calcium channel blocker resistance protein CCBR1) (Solute carrier family 7 member 11) (xCT)","SLC7A11","FUNCTION: Sodium-independent, high-affinity exchange of anionic amino acids with high specificity for anionic form of cystine and glutamate. {ECO:0000269|PubMed:15151999}.","SLC7A11","apical part of cell [GO:0045177]; astrocyte projection [GO:0097449]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; cystine:glutamate antiporter activity [GO:0015327]; L-amino acid transmembrane transporter activity [GO:0015179]; adult behavior [GO:0030534]; cellular response to oxidative stress [GO:0034599]; dipeptide import across plasma membrane [GO:0140206]; glutamate homeostasis [GO:0090461]; glutathione metabolic process [GO:0006749]; glutathione transmembrane transport [GO:0034775]; L-glutamate import across plasma membrane [GO:0098712]; lens fiber cell differentiation [GO:0070306]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; platelet aggregation [GO:0070527]; regulation of AMPA glutamate receptor clustering [GO:1904717]; regulation of cell population proliferation [GO:0042127]; regulation of cysteine metabolic process [GO:1901494]; regulation of glutamate metabolic process [GO:2000211]; regulation of glutathione biosynthetic process [GO:1903786]; regulation of melanin biosynthetic process [GO:0048021]; regulation of neutrophil apoptotic process [GO:0033029]; regulation of protein transport [GO:0051223]; regulation of synapse organization [GO:0050807]; response to nicotine [GO:0035094]; response to organic cyclic compound [GO:0014070]; response to redox state [GO:0051775]; response to toxic substance [GO:0009636]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual learning [GO:0008542]","P16070; Q07627; Q8IUG1; P08195-4","SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:15151999}; Multi-pass membrane protein {ECO:0000269|PubMed:15151999}.","ENST00000280612.9;",1.61935462452614e-07
"16520","SLITRK4",1.38787080106096,3.52796766298509,25.9311072208876,1.45755139077435e-06,"Q8IW52","Q8IW52","reviewed","SLIK4_HUMAN","SLIT and NTRK-like protein 4","SLITRK4","FUNCTION: It is involved in synaptogenesis and promotes synapse differentiation (PubMed:27812321). Suppresses neurite outgrowth (By similarity). {ECO:0000250|UniProtKB:Q810B8, ECO:0000269|PubMed:27812321}.","SLITRK4","glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; axonogenesis [GO:0007409]; positive regulation of synapse assembly [GO:0051965]; regulation of presynapse assembly [GO:1905606]; regulation of synapse organization [GO:0050807]","","SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}. Cell membrane {ECO:0000269|PubMed:27812321}.","ENST00000338017.8;ENST00000356928.2;ENST00000596188.2;",0.000950129166599437
